Rockwell Automation and Industry Leaders Launch the Digital CMC Consortium to Accelerate Digital Transformation in Pharmaceutical Development
PR Newswire•08/10/2026•09:00 ET
0
Key Highlights
- ➤Rockwell Automation (ROK) co-founds Digital CMC Consortium for pharmaceutical development
- ➤Consortium targets digital technology transfer and structured knowledge exchange between sponsors and CDMOs
- ➤Longer-term plans include knowledge management, automated content authoring, digital twins and artificial intelligence
- ➤Founding members include Novartis, Thermo Fisher Scientific, Takeda and other CMC ecosystem leaders
Expert Statements
Matt Weaver, Vice president, global industry – life sciences, Rockwell Automation
“Digital transformation in life sciences is not just about technology adoption, it is about building new ways of working that improve how therapies are developed and delivered.”
Matt Weaver, Vice president, global industry – life sciences, Rockwell Automation
“The Consortium reflects the partnership-driven approach needed to advance the pharma industry.”
Matt Weaver, Vice president, global industry – life sciences, Rockwell Automation
“With deep life sciences expertise and experience supporting both pharma innovators and the CDMOs, we are proud to work alongside fellow founding members to help shape the future of pharmaceutical manufacturing and CMC digitization, connecting development, manufacturing and commercialization across product lifecycle.”
Rockwell Automation and Industry Leaders Launch the Digital CMC Consortium to Accelerate Digital Transformation in Pharmaceutical Development PR Newswire
New industry collaboration addresses pharma's most complex development challenges and expedites patient access to breakthrough therapies
Get started
Create a free account to read the full story.